nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfuzosin—CYP3A4—breast cancer	0.252	1	CbGaD
Alfuzosin—CYP3A4—Exemestane—breast cancer	0.0537	0.133	CbGbCtD
Alfuzosin—CYP3A4—Letrozole—breast cancer	0.0456	0.113	CbGbCtD
Alfuzosin—CYP3A4—Anastrozole—breast cancer	0.0407	0.101	CbGbCtD
Alfuzosin—CYP3A4—Toremifene—breast cancer	0.0372	0.0921	CbGbCtD
Alfuzosin—CYP3A4—Fulvestrant—breast cancer	0.0346	0.0856	CbGbCtD
Alfuzosin—CYP3A4—Thiotepa—breast cancer	0.0308	0.0763	CbGbCtD
Alfuzosin—CYP3A4—Ixabepilone—breast cancer	0.0282	0.0698	CbGbCtD
Alfuzosin—CYP3A4—Lapatinib—breast cancer	0.0271	0.0672	CbGbCtD
Alfuzosin—CYP3A4—Raloxifene—breast cancer	0.0206	0.0509	CbGbCtD
Alfuzosin—CYP3A4—Vinorelbine—breast cancer	0.0151	0.0373	CbGbCtD
Alfuzosin—CYP3A4—Tamoxifen—breast cancer	0.0136	0.0336	CbGbCtD
Alfuzosin—CYP3A4—Mitoxantrone—breast cancer	0.0133	0.0328	CbGbCtD
Alfuzosin—CYP3A4—Paclitaxel—breast cancer	0.0106	0.0262	CbGbCtD
Alfuzosin—CYP3A4—Irinotecan—breast cancer	0.0104	0.0258	CbGbCtD
Alfuzosin—CYP3A4—Vinblastine—breast cancer	0.00928	0.023	CbGbCtD
Alfuzosin—CYP3A4—Docetaxel—breast cancer	0.00765	0.0189	CbGbCtD
Alfuzosin—CYP3A4—Doxorubicin—breast cancer	0.0057	0.0141	CbGbCtD
Alfuzosin—Prazosin—MT3—breast cancer	0.0036	0.564	CrCbGaD
Alfuzosin—Prazosin—ABCG2—breast cancer	0.000715	0.112	CrCbGaD
Alfuzosin—Prazosin—CYP1A1—breast cancer	0.00056	0.0877	CrCbGaD
Alfuzosin—Doxazosin—CYP2D6—breast cancer	0.000452	0.0708	CrCbGaD
Alfuzosin—Terazosin—ABCB1—breast cancer	0.000434	0.068	CrCbGaD
Alfuzosin—Doxazosin—ABCB1—breast cancer	0.000323	0.0506	CrCbGaD
Alfuzosin—Prazosin—ABCB1—breast cancer	0.000298	0.0466	CrCbGaD
Alfuzosin—Discomfort—Capecitabine—breast cancer	9.37e-05	0.000339	CcSEcCtD
Alfuzosin—Pruritus—Gemcitabine—breast cancer	9.36e-05	0.000339	CcSEcCtD
Alfuzosin—Nausea—Thiotepa—breast cancer	9.34e-05	0.000338	CcSEcCtD
Alfuzosin—Urethral disorder—Methotrexate—breast cancer	9.34e-05	0.000338	CcSEcCtD
Alfuzosin—Infection—Docetaxel—breast cancer	9.33e-05	0.000338	CcSEcCtD
Alfuzosin—Sinusitis—Epirubicin—breast cancer	9.32e-05	0.000337	CcSEcCtD
Alfuzosin—Diarrhoea—Mitoxantrone—breast cancer	9.29e-05	0.000337	CcSEcCtD
Alfuzosin—Diarrhoea—Irinotecan—breast cancer	9.29e-05	0.000337	CcSEcCtD
Alfuzosin—Dry mouth—Capecitabine—breast cancer	9.27e-05	0.000336	CcSEcCtD
Alfuzosin—Shock—Docetaxel—breast cancer	9.24e-05	0.000335	CcSEcCtD
Alfuzosin—Nervous system disorder—Docetaxel—breast cancer	9.21e-05	0.000334	CcSEcCtD
Alfuzosin—Pruritus—Fluorouracil—breast cancer	9.2e-05	0.000333	CcSEcCtD
Alfuzosin—Thrombocytopenia—Docetaxel—breast cancer	9.19e-05	0.000333	CcSEcCtD
Alfuzosin—Infestation NOS—Doxorubicin—breast cancer	9.19e-05	0.000333	CcSEcCtD
Alfuzosin—Drowsiness—Doxorubicin—breast cancer	9.19e-05	0.000333	CcSEcCtD
Alfuzosin—Infestation—Doxorubicin—breast cancer	9.19e-05	0.000333	CcSEcCtD
Alfuzosin—Tachycardia—Docetaxel—breast cancer	9.16e-05	0.000332	CcSEcCtD
Alfuzosin—Feeling abnormal—Paclitaxel—breast cancer	9.13e-05	0.000331	CcSEcCtD
Alfuzosin—Skin disorder—Docetaxel—breast cancer	9.12e-05	0.00033	CcSEcCtD
Alfuzosin—Oedema—Capecitabine—breast cancer	9.09e-05	0.000329	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Paclitaxel—breast cancer	9.06e-05	0.000328	CcSEcCtD
Alfuzosin—Diarrhoea—Gemcitabine—breast cancer	9.05e-05	0.000328	CcSEcCtD
Alfuzosin—Infection—Capecitabine—breast cancer	9.03e-05	0.000327	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Doxorubicin—breast cancer	9.01e-05	0.000326	CcSEcCtD
Alfuzosin—Dizziness—Irinotecan—breast cancer	8.98e-05	0.000325	CcSEcCtD
Alfuzosin—Jaundice—Doxorubicin—breast cancer	8.96e-05	0.000324	CcSEcCtD
Alfuzosin—Shock—Capecitabine—breast cancer	8.94e-05	0.000324	CcSEcCtD
Alfuzosin—Rhinitis—Epirubicin—breast cancer	8.94e-05	0.000324	CcSEcCtD
Alfuzosin—Nervous system disorder—Capecitabine—breast cancer	8.92e-05	0.000323	CcSEcCtD
Alfuzosin—Eye disorder—Methotrexate—breast cancer	8.9e-05	0.000322	CcSEcCtD
Alfuzosin—Diarrhoea—Fluorouracil—breast cancer	8.9e-05	0.000322	CcSEcCtD
Alfuzosin—Thrombocytopenia—Capecitabine—breast cancer	8.9e-05	0.000322	CcSEcCtD
Alfuzosin—Tachycardia—Capecitabine—breast cancer	8.87e-05	0.000321	CcSEcCtD
Alfuzosin—Pharyngitis—Epirubicin—breast cancer	8.85e-05	0.00032	CcSEcCtD
Alfuzosin—Cardiac disorder—Methotrexate—breast cancer	8.84e-05	0.00032	CcSEcCtD
Alfuzosin—Skin disorder—Capecitabine—breast cancer	8.83e-05	0.00032	CcSEcCtD
Alfuzosin—Sweating—Doxorubicin—breast cancer	8.81e-05	0.000319	CcSEcCtD
Alfuzosin—Urinary tract disorder—Epirubicin—breast cancer	8.8e-05	0.000319	CcSEcCtD
Alfuzosin—Urticaria—Paclitaxel—breast cancer	8.8e-05	0.000319	CcSEcCtD
Alfuzosin—Hyperhidrosis—Capecitabine—breast cancer	8.79e-05	0.000318	CcSEcCtD
Alfuzosin—Hypotension—Docetaxel—breast cancer	8.77e-05	0.000318	CcSEcCtD
Alfuzosin—Connective tissue disorder—Epirubicin—breast cancer	8.76e-05	0.000317	CcSEcCtD
Alfuzosin—Abdominal pain—Paclitaxel—breast cancer	8.76e-05	0.000317	CcSEcCtD
Alfuzosin—Urethral disorder—Epirubicin—breast cancer	8.74e-05	0.000316	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Doxorubicin—breast cancer	8.69e-05	0.000315	CcSEcCtD
Alfuzosin—Angiopathy—Methotrexate—breast cancer	8.64e-05	0.000313	CcSEcCtD
Alfuzosin—Vomiting—Mitoxantrone—breast cancer	8.64e-05	0.000313	CcSEcCtD
Alfuzosin—Vomiting—Irinotecan—breast cancer	8.64e-05	0.000313	CcSEcCtD
Alfuzosin—Sinusitis—Doxorubicin—breast cancer	8.62e-05	0.000312	CcSEcCtD
Alfuzosin—Dizziness—Fluorouracil—breast cancer	8.6e-05	0.000312	CcSEcCtD
Alfuzosin—Mediastinal disorder—Methotrexate—breast cancer	8.58e-05	0.000311	CcSEcCtD
Alfuzosin—Rash—Mitoxantrone—breast cancer	8.56e-05	0.00031	CcSEcCtD
Alfuzosin—Rash—Irinotecan—breast cancer	8.56e-05	0.00031	CcSEcCtD
Alfuzosin—Dermatitis—Mitoxantrone—breast cancer	8.56e-05	0.00031	CcSEcCtD
Alfuzosin—Dermatitis—Irinotecan—breast cancer	8.56e-05	0.00031	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Docetaxel—breast cancer	8.55e-05	0.00031	CcSEcCtD
Alfuzosin—Headache—Irinotecan—breast cancer	8.51e-05	0.000308	CcSEcCtD
Alfuzosin—Headache—Mitoxantrone—breast cancer	8.51e-05	0.000308	CcSEcCtD
Alfuzosin—Hypotension—Capecitabine—breast cancer	8.49e-05	0.000308	CcSEcCtD
Alfuzosin—Vomiting—Gemcitabine—breast cancer	8.41e-05	0.000305	CcSEcCtD
Alfuzosin—Somnolence—Docetaxel—breast cancer	8.35e-05	0.000302	CcSEcCtD
Alfuzosin—Mental disorder—Methotrexate—breast cancer	8.35e-05	0.000302	CcSEcCtD
Alfuzosin—Rash—Gemcitabine—breast cancer	8.34e-05	0.000302	CcSEcCtD
Alfuzosin—Dermatitis—Gemcitabine—breast cancer	8.33e-05	0.000302	CcSEcCtD
Alfuzosin—Eye disorder—Epirubicin—breast cancer	8.33e-05	0.000302	CcSEcCtD
Alfuzosin—Headache—Gemcitabine—breast cancer	8.29e-05	0.0003	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Capecitabine—breast cancer	8.28e-05	0.0003	CcSEcCtD
Alfuzosin—Flushing—Epirubicin—breast cancer	8.27e-05	0.0003	CcSEcCtD
Alfuzosin—Cardiac disorder—Epirubicin—breast cancer	8.27e-05	0.0003	CcSEcCtD
Alfuzosin—Vomiting—Fluorouracil—breast cancer	8.27e-05	0.0003	CcSEcCtD
Alfuzosin—Rhinitis—Doxorubicin—breast cancer	8.27e-05	0.000299	CcSEcCtD
Alfuzosin—Dyspepsia—Docetaxel—breast cancer	8.27e-05	0.000299	CcSEcCtD
Alfuzosin—Rash—Fluorouracil—breast cancer	8.2e-05	0.000297	CcSEcCtD
Alfuzosin—Dermatitis—Fluorouracil—breast cancer	8.2e-05	0.000297	CcSEcCtD
Alfuzosin—Pharyngitis—Doxorubicin—breast cancer	8.19e-05	0.000296	CcSEcCtD
Alfuzosin—Headache—Fluorouracil—breast cancer	8.15e-05	0.000295	CcSEcCtD
Alfuzosin—Urinary tract disorder—Doxorubicin—breast cancer	8.15e-05	0.000295	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Docetaxel—breast cancer	8.11e-05	0.000294	CcSEcCtD
Alfuzosin—Connective tissue disorder—Doxorubicin—breast cancer	8.11e-05	0.000294	CcSEcCtD
Alfuzosin—Fatigue—Docetaxel—breast cancer	8.1e-05	0.000293	CcSEcCtD
Alfuzosin—Angiopathy—Epirubicin—breast cancer	8.09e-05	0.000293	CcSEcCtD
Alfuzosin—Urethral disorder—Doxorubicin—breast cancer	8.09e-05	0.000293	CcSEcCtD
Alfuzosin—Nausea—Irinotecan—breast cancer	8.07e-05	0.000292	CcSEcCtD
Alfuzosin—Nausea—Mitoxantrone—breast cancer	8.07e-05	0.000292	CcSEcCtD
Alfuzosin—Mediastinal disorder—Epirubicin—breast cancer	8.03e-05	0.000291	CcSEcCtD
Alfuzosin—Constipation—Docetaxel—breast cancer	8.03e-05	0.000291	CcSEcCtD
Alfuzosin—Pain—Docetaxel—breast cancer	8.03e-05	0.000291	CcSEcCtD
Alfuzosin—Back pain—Methotrexate—breast cancer	8.02e-05	0.000291	CcSEcCtD
Alfuzosin—Dyspepsia—Capecitabine—breast cancer	8e-05	0.00029	CcSEcCtD
Alfuzosin—Asthenia—Paclitaxel—breast cancer	7.95e-05	0.000288	CcSEcCtD
Alfuzosin—Nausea—Gemcitabine—breast cancer	7.86e-05	0.000285	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Capecitabine—breast cancer	7.85e-05	0.000284	CcSEcCtD
Alfuzosin—Fatigue—Capecitabine—breast cancer	7.84e-05	0.000284	CcSEcCtD
Alfuzosin—Pruritus—Paclitaxel—breast cancer	7.84e-05	0.000284	CcSEcCtD
Alfuzosin—Mental disorder—Epirubicin—breast cancer	7.81e-05	0.000283	CcSEcCtD
Alfuzosin—Constipation—Capecitabine—breast cancer	7.77e-05	0.000282	CcSEcCtD
Alfuzosin—Pain—Capecitabine—breast cancer	7.77e-05	0.000282	CcSEcCtD
Alfuzosin—Feeling abnormal—Docetaxel—breast cancer	7.74e-05	0.00028	CcSEcCtD
Alfuzosin—Nausea—Fluorouracil—breast cancer	7.73e-05	0.00028	CcSEcCtD
Alfuzosin—Eye disorder—Doxorubicin—breast cancer	7.71e-05	0.000279	CcSEcCtD
Alfuzosin—Ill-defined disorder—Methotrexate—breast cancer	7.69e-05	0.000279	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Docetaxel—breast cancer	7.68e-05	0.000278	CcSEcCtD
Alfuzosin—Flushing—Doxorubicin—breast cancer	7.66e-05	0.000277	CcSEcCtD
Alfuzosin—Cardiac disorder—Doxorubicin—breast cancer	7.66e-05	0.000277	CcSEcCtD
Alfuzosin—Diarrhoea—Paclitaxel—breast cancer	7.58e-05	0.000275	CcSEcCtD
Alfuzosin—Back pain—Epirubicin—breast cancer	7.51e-05	0.000272	CcSEcCtD
Alfuzosin—Feeling abnormal—Capecitabine—breast cancer	7.49e-05	0.000271	CcSEcCtD
Alfuzosin—Angiopathy—Doxorubicin—breast cancer	7.48e-05	0.000271	CcSEcCtD
Alfuzosin—Malaise—Methotrexate—breast cancer	7.48e-05	0.000271	CcSEcCtD
Alfuzosin—Vertigo—Methotrexate—breast cancer	7.45e-05	0.00027	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Capecitabine—breast cancer	7.43e-05	0.000269	CcSEcCtD
Alfuzosin—Mediastinal disorder—Doxorubicin—breast cancer	7.43e-05	0.000269	CcSEcCtD
Alfuzosin—Abdominal pain—Docetaxel—breast cancer	7.42e-05	0.000269	CcSEcCtD
Alfuzosin—Dizziness—Paclitaxel—breast cancer	7.33e-05	0.000265	CcSEcCtD
Alfuzosin—Mental disorder—Doxorubicin—breast cancer	7.23e-05	0.000262	CcSEcCtD
Alfuzosin—Urticaria—Capecitabine—breast cancer	7.22e-05	0.000262	CcSEcCtD
Alfuzosin—Ill-defined disorder—Epirubicin—breast cancer	7.2e-05	0.000261	CcSEcCtD
Alfuzosin—Abdominal pain—Capecitabine—breast cancer	7.19e-05	0.00026	CcSEcCtD
Alfuzosin—Chest pain—Methotrexate—breast cancer	7.06e-05	0.000256	CcSEcCtD
Alfuzosin—Arthralgia—Methotrexate—breast cancer	7.06e-05	0.000256	CcSEcCtD
Alfuzosin—Vomiting—Paclitaxel—breast cancer	7.04e-05	0.000255	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	7.01e-05	0.000254	CcSEcCtD
Alfuzosin—Malaise—Epirubicin—breast cancer	7e-05	0.000253	CcSEcCtD
Alfuzosin—Rash—Paclitaxel—breast cancer	6.98e-05	0.000253	CcSEcCtD
Alfuzosin—Dermatitis—Paclitaxel—breast cancer	6.98e-05	0.000253	CcSEcCtD
Alfuzosin—Discomfort—Methotrexate—breast cancer	6.98e-05	0.000253	CcSEcCtD
Alfuzosin—Vertigo—Epirubicin—breast cancer	6.97e-05	0.000253	CcSEcCtD
Alfuzosin—Syncope—Epirubicin—breast cancer	6.96e-05	0.000252	CcSEcCtD
Alfuzosin—Back pain—Doxorubicin—breast cancer	6.95e-05	0.000252	CcSEcCtD
Alfuzosin—Headache—Paclitaxel—breast cancer	6.94e-05	0.000251	CcSEcCtD
Alfuzosin—Palpitations—Epirubicin—breast cancer	6.86e-05	0.000248	CcSEcCtD
Alfuzosin—Loss of consciousness—Epirubicin—breast cancer	6.82e-05	0.000247	CcSEcCtD
Alfuzosin—Asthenia—Docetaxel—breast cancer	6.74e-05	0.000244	CcSEcCtD
Alfuzosin—Infection—Methotrexate—breast cancer	6.72e-05	0.000244	CcSEcCtD
Alfuzosin—Ill-defined disorder—Doxorubicin—breast cancer	6.66e-05	0.000241	CcSEcCtD
Alfuzosin—Pruritus—Docetaxel—breast cancer	6.64e-05	0.000241	CcSEcCtD
Alfuzosin—Nervous system disorder—Methotrexate—breast cancer	6.64e-05	0.00024	CcSEcCtD
Alfuzosin—Thrombocytopenia—Methotrexate—breast cancer	6.63e-05	0.00024	CcSEcCtD
Alfuzosin—Chest pain—Epirubicin—breast cancer	6.61e-05	0.000239	CcSEcCtD
Alfuzosin—Arthralgia—Epirubicin—breast cancer	6.61e-05	0.000239	CcSEcCtD
Alfuzosin—Nausea—Paclitaxel—breast cancer	6.58e-05	0.000238	CcSEcCtD
Alfuzosin—Skin disorder—Methotrexate—breast cancer	6.57e-05	0.000238	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	6.56e-05	0.000238	CcSEcCtD
Alfuzosin—Hyperhidrosis—Methotrexate—breast cancer	6.54e-05	0.000237	CcSEcCtD
Alfuzosin—Discomfort—Epirubicin—breast cancer	6.53e-05	0.000236	CcSEcCtD
Alfuzosin—Asthenia—Capecitabine—breast cancer	6.52e-05	0.000236	CcSEcCtD
Alfuzosin—Malaise—Doxorubicin—breast cancer	6.48e-05	0.000235	CcSEcCtD
Alfuzosin—Dry mouth—Epirubicin—breast cancer	6.46e-05	0.000234	CcSEcCtD
Alfuzosin—Vertigo—Doxorubicin—breast cancer	6.45e-05	0.000234	CcSEcCtD
Alfuzosin—Syncope—Doxorubicin—breast cancer	6.44e-05	0.000233	CcSEcCtD
Alfuzosin—Pruritus—Capecitabine—breast cancer	6.43e-05	0.000233	CcSEcCtD
Alfuzosin—Diarrhoea—Docetaxel—breast cancer	6.42e-05	0.000233	CcSEcCtD
Alfuzosin—Palpitations—Doxorubicin—breast cancer	6.35e-05	0.00023	CcSEcCtD
Alfuzosin—Oedema—Epirubicin—breast cancer	6.33e-05	0.000229	CcSEcCtD
Alfuzosin—Hypotension—Methotrexate—breast cancer	6.32e-05	0.000229	CcSEcCtD
Alfuzosin—Loss of consciousness—Doxorubicin—breast cancer	6.31e-05	0.000229	CcSEcCtD
Alfuzosin—Infection—Epirubicin—breast cancer	6.29e-05	0.000228	CcSEcCtD
Alfuzosin—Shock—Epirubicin—breast cancer	6.23e-05	0.000226	CcSEcCtD
Alfuzosin—Diarrhoea—Capecitabine—breast cancer	6.22e-05	0.000225	CcSEcCtD
Alfuzosin—Nervous system disorder—Epirubicin—breast cancer	6.21e-05	0.000225	CcSEcCtD
Alfuzosin—Dizziness—Docetaxel—breast cancer	6.21e-05	0.000225	CcSEcCtD
Alfuzosin—Thrombocytopenia—Epirubicin—breast cancer	6.2e-05	0.000225	CcSEcCtD
Alfuzosin—Tachycardia—Epirubicin—breast cancer	6.18e-05	0.000224	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Methotrexate—breast cancer	6.17e-05	0.000223	CcSEcCtD
Alfuzosin—Skin disorder—Epirubicin—breast cancer	6.15e-05	0.000223	CcSEcCtD
Alfuzosin—Hyperhidrosis—Epirubicin—breast cancer	6.12e-05	0.000222	CcSEcCtD
Alfuzosin—Chest pain—Doxorubicin—breast cancer	6.11e-05	0.000221	CcSEcCtD
Alfuzosin—Arthralgia—Doxorubicin—breast cancer	6.11e-05	0.000221	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	6.07e-05	0.00022	CcSEcCtD
Alfuzosin—Discomfort—Doxorubicin—breast cancer	6.04e-05	0.000219	CcSEcCtD
Alfuzosin—Somnolence—Methotrexate—breast cancer	6.02e-05	0.000218	CcSEcCtD
Alfuzosin—Dizziness—Capecitabine—breast cancer	6.01e-05	0.000218	CcSEcCtD
Alfuzosin—Dry mouth—Doxorubicin—breast cancer	5.98e-05	0.000217	CcSEcCtD
Alfuzosin—Vomiting—Docetaxel—breast cancer	5.97e-05	0.000216	CcSEcCtD
Alfuzosin—Dyspepsia—Methotrexate—breast cancer	5.96e-05	0.000216	CcSEcCtD
Alfuzosin—Rash—Docetaxel—breast cancer	5.92e-05	0.000214	CcSEcCtD
Alfuzosin—Hypotension—Epirubicin—breast cancer	5.92e-05	0.000214	CcSEcCtD
Alfuzosin—Dermatitis—Docetaxel—breast cancer	5.91e-05	0.000214	CcSEcCtD
Alfuzosin—Headache—Docetaxel—breast cancer	5.88e-05	0.000213	CcSEcCtD
Alfuzosin—Oedema—Doxorubicin—breast cancer	5.86e-05	0.000212	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Methotrexate—breast cancer	5.84e-05	0.000212	CcSEcCtD
Alfuzosin—Fatigue—Methotrexate—breast cancer	5.83e-05	0.000211	CcSEcCtD
Alfuzosin—Infection—Doxorubicin—breast cancer	5.82e-05	0.000211	CcSEcCtD
Alfuzosin—Pain—Methotrexate—breast cancer	5.79e-05	0.00021	CcSEcCtD
Alfuzosin—Vomiting—Capecitabine—breast cancer	5.78e-05	0.000209	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Epirubicin—breast cancer	5.77e-05	0.000209	CcSEcCtD
Alfuzosin—Shock—Doxorubicin—breast cancer	5.77e-05	0.000209	CcSEcCtD
Alfuzosin—Nervous system disorder—Doxorubicin—breast cancer	5.75e-05	0.000208	CcSEcCtD
Alfuzosin—Thrombocytopenia—Doxorubicin—breast cancer	5.74e-05	0.000208	CcSEcCtD
Alfuzosin—Rash—Capecitabine—breast cancer	5.73e-05	0.000208	CcSEcCtD
Alfuzosin—Dermatitis—Capecitabine—breast cancer	5.73e-05	0.000207	CcSEcCtD
Alfuzosin—Tachycardia—Doxorubicin—breast cancer	5.72e-05	0.000207	CcSEcCtD
Alfuzosin—Headache—Capecitabine—breast cancer	5.7e-05	0.000206	CcSEcCtD
Alfuzosin—Skin disorder—Doxorubicin—breast cancer	5.69e-05	0.000206	CcSEcCtD
Alfuzosin—Hyperhidrosis—Doxorubicin—breast cancer	5.67e-05	0.000205	CcSEcCtD
Alfuzosin—Somnolence—Epirubicin—breast cancer	5.63e-05	0.000204	CcSEcCtD
Alfuzosin—Nausea—Docetaxel—breast cancer	5.58e-05	0.000202	CcSEcCtD
Alfuzosin—Feeling abnormal—Methotrexate—breast cancer	5.58e-05	0.000202	CcSEcCtD
Alfuzosin—Dyspepsia—Epirubicin—breast cancer	5.57e-05	0.000202	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Methotrexate—breast cancer	5.53e-05	0.0002	CcSEcCtD
Alfuzosin—Hypotension—Doxorubicin—breast cancer	5.48e-05	0.000198	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Epirubicin—breast cancer	5.47e-05	0.000198	CcSEcCtD
Alfuzosin—Fatigue—Epirubicin—breast cancer	5.46e-05	0.000198	CcSEcCtD
Alfuzosin—Pain—Epirubicin—breast cancer	5.42e-05	0.000196	CcSEcCtD
Alfuzosin—Constipation—Epirubicin—breast cancer	5.42e-05	0.000196	CcSEcCtD
Alfuzosin—Nausea—Capecitabine—breast cancer	5.4e-05	0.000196	CcSEcCtD
Alfuzosin—Urticaria—Methotrexate—breast cancer	5.38e-05	0.000195	CcSEcCtD
Alfuzosin—Abdominal pain—Methotrexate—breast cancer	5.35e-05	0.000194	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Doxorubicin—breast cancer	5.34e-05	0.000193	CcSEcCtD
Alfuzosin—Feeling abnormal—Epirubicin—breast cancer	5.22e-05	0.000189	CcSEcCtD
Alfuzosin—Somnolence—Doxorubicin—breast cancer	5.21e-05	0.000189	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Epirubicin—breast cancer	5.18e-05	0.000188	CcSEcCtD
Alfuzosin—Dyspepsia—Doxorubicin—breast cancer	5.16e-05	0.000187	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Doxorubicin—breast cancer	5.06e-05	0.000183	CcSEcCtD
Alfuzosin—Fatigue—Doxorubicin—breast cancer	5.05e-05	0.000183	CcSEcCtD
Alfuzosin—Urticaria—Epirubicin—breast cancer	5.03e-05	0.000182	CcSEcCtD
Alfuzosin—Constipation—Doxorubicin—breast cancer	5.01e-05	0.000181	CcSEcCtD
Alfuzosin—Pain—Doxorubicin—breast cancer	5.01e-05	0.000181	CcSEcCtD
Alfuzosin—Abdominal pain—Epirubicin—breast cancer	5.01e-05	0.000181	CcSEcCtD
Alfuzosin—Asthenia—Methotrexate—breast cancer	4.86e-05	0.000176	CcSEcCtD
Alfuzosin—Feeling abnormal—Doxorubicin—breast cancer	4.83e-05	0.000175	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Doxorubicin—breast cancer	4.79e-05	0.000174	CcSEcCtD
Alfuzosin—Pruritus—Methotrexate—breast cancer	4.79e-05	0.000173	CcSEcCtD
Alfuzosin—Urticaria—Doxorubicin—breast cancer	4.66e-05	0.000169	CcSEcCtD
Alfuzosin—Abdominal pain—Doxorubicin—breast cancer	4.63e-05	0.000168	CcSEcCtD
Alfuzosin—Diarrhoea—Methotrexate—breast cancer	4.63e-05	0.000168	CcSEcCtD
Alfuzosin—Asthenia—Epirubicin—breast cancer	4.54e-05	0.000165	CcSEcCtD
Alfuzosin—Pruritus—Epirubicin—breast cancer	4.48e-05	0.000162	CcSEcCtD
Alfuzosin—Dizziness—Methotrexate—breast cancer	4.48e-05	0.000162	CcSEcCtD
Alfuzosin—Diarrhoea—Epirubicin—breast cancer	4.33e-05	0.000157	CcSEcCtD
Alfuzosin—Vomiting—Methotrexate—breast cancer	4.3e-05	0.000156	CcSEcCtD
Alfuzosin—Rash—Methotrexate—breast cancer	4.27e-05	0.000155	CcSEcCtD
Alfuzosin—Dermatitis—Methotrexate—breast cancer	4.26e-05	0.000154	CcSEcCtD
Alfuzosin—Headache—Methotrexate—breast cancer	4.24e-05	0.000154	CcSEcCtD
Alfuzosin—Asthenia—Doxorubicin—breast cancer	4.2e-05	0.000152	CcSEcCtD
Alfuzosin—Dizziness—Epirubicin—breast cancer	4.19e-05	0.000152	CcSEcCtD
Alfuzosin—Pruritus—Doxorubicin—breast cancer	4.15e-05	0.00015	CcSEcCtD
Alfuzosin—Vomiting—Epirubicin—breast cancer	4.03e-05	0.000146	CcSEcCtD
Alfuzosin—Nausea—Methotrexate—breast cancer	4.02e-05	0.000146	CcSEcCtD
Alfuzosin—Diarrhoea—Doxorubicin—breast cancer	4.01e-05	0.000145	CcSEcCtD
Alfuzosin—Rash—Epirubicin—breast cancer	3.99e-05	0.000145	CcSEcCtD
Alfuzosin—Dermatitis—Epirubicin—breast cancer	3.99e-05	0.000144	CcSEcCtD
Alfuzosin—Headache—Epirubicin—breast cancer	3.97e-05	0.000144	CcSEcCtD
Alfuzosin—Dizziness—Doxorubicin—breast cancer	3.88e-05	0.00014	CcSEcCtD
Alfuzosin—Nausea—Epirubicin—breast cancer	3.76e-05	0.000136	CcSEcCtD
Alfuzosin—Vomiting—Doxorubicin—breast cancer	3.73e-05	0.000135	CcSEcCtD
Alfuzosin—Rash—Doxorubicin—breast cancer	3.69e-05	0.000134	CcSEcCtD
Alfuzosin—Dermatitis—Doxorubicin—breast cancer	3.69e-05	0.000134	CcSEcCtD
Alfuzosin—Headache—Doxorubicin—breast cancer	3.67e-05	0.000133	CcSEcCtD
Alfuzosin—Nausea—Doxorubicin—breast cancer	3.48e-05	0.000126	CcSEcCtD
Alfuzosin—ADRA1D—Signaling Pathways—NFKBIA—breast cancer	8.64e-06	0.000141	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—ERBB3—breast cancer	8.6e-06	0.00014	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—FGFR2—breast cancer	8.58e-06	0.00014	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GSTA4—breast cancer	8.56e-06	0.00014	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CA9—breast cancer	8.56e-06	0.00014	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—SMAD4—breast cancer	8.56e-06	0.000139	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—NOTCH1—breast cancer	8.55e-06	0.000139	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—IGF1R—breast cancer	8.5e-06	0.000139	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—CXCL8—breast cancer	8.47e-06	0.000138	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—APC—breast cancer	8.37e-06	0.000136	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PIK3CG—breast cancer	8.37e-06	0.000136	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—KIT—breast cancer	8.37e-06	0.000136	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—HES1—breast cancer	8.35e-06	0.000136	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GSTA2—breast cancer	8.34e-06	0.000136	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GPX2—breast cancer	8.34e-06	0.000136	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—NCOR1—breast cancer	8.31e-06	0.000135	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PLA2G4A—breast cancer	8.31e-06	0.000135	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—IL2—breast cancer	8.27e-06	0.000135	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—EGF—breast cancer	8.27e-06	0.000135	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GPX4—breast cancer	8.24e-06	0.000134	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—SULT1A1—breast cancer	8.24e-06	0.000134	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—TERT—breast cancer	8.24e-06	0.000134	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—FGF1—breast cancer	8.21e-06	0.000134	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CSF2—breast cancer	8.21e-06	0.000134	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—RAF1—breast cancer	8.19e-06	0.000134	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—NRG1—breast cancer	8.15e-06	0.000133	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—H2AFX—breast cancer	8.09e-06	0.000132	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—IL2—breast cancer	8.09e-06	0.000132	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GSTA1—breast cancer	8.05e-06	0.000131	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—IDH1—breast cancer	8.05e-06	0.000131	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—E2F1—breast cancer	8.04e-06	0.000131	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—MAPK3—breast cancer	8.01e-06	0.000131	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—FGFR1—breast cancer	8e-06	0.00013	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—PIK3CB—breast cancer	8e-06	0.00013	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—NAT2—breast cancer	7.96e-06	0.00013	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—HIF1A—breast cancer	7.88e-06	0.000128	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—BRAF—breast cancer	7.86e-06	0.000128	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—SPP1—breast cancer	7.72e-06	0.000126	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—LEP—breast cancer	7.69e-06	0.000125	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—CXCL8—breast cancer	7.69e-06	0.000125	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—IGF1—breast cancer	7.66e-06	0.000125	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—AKT2—breast cancer	7.65e-06	0.000125	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—ERBB3—breast cancer	7.64e-06	0.000124	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—FGFR2—breast cancer	7.63e-06	0.000124	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CAV1—breast cancer	7.62e-06	0.000124	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—EGFR—breast cancer	7.62e-06	0.000124	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—KDR—breast cancer	7.54e-06	0.000123	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PIK3CD—breast cancer	7.35e-06	0.00012	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—IL2—breast cancer	7.35e-06	0.00012	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—ESR1—breast cancer	7.34e-06	0.00012	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—TERT—breast cancer	7.32e-06	0.000119	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—PIK3CA—breast cancer	7.28e-06	0.000119	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—SERPINE1—breast cancer	7.27e-06	0.000119	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—FN1—breast cancer	7.26e-06	0.000118	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—KRAS—breast cancer	7.2e-06	0.000117	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—NFKBIA—breast cancer	7.17e-06	0.000117	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—FGFR1—breast cancer	7.11e-06	0.000116	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—NOTCH1—breast cancer	7.1e-06	0.000116	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—HIF1A—breast cancer	7e-06	0.000114	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—DPYD—breast cancer	6.98e-06	0.000114	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—MED12—breast cancer	6.98e-06	0.000114	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—NOS3—breast cancer	6.94e-06	0.000113	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PIK3CG—breast cancer	6.94e-06	0.000113	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—APC—breast cancer	6.94e-06	0.000113	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—KIT—breast cancer	6.94e-06	0.000113	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ALDOA—breast cancer	6.87e-06	0.000112	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—EGF—breast cancer	6.86e-06	0.000112	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—LEP—breast cancer	6.83e-06	0.000111	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CAV1—breast cancer	6.77e-06	0.00011	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—KDR—breast cancer	6.69e-06	0.000109	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—NCOA3—breast cancer	6.67e-06	0.000109	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—MAPK3—breast cancer	6.65e-06	0.000108	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—SLC2A2—breast cancer	6.62e-06	0.000108	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—PIK3CA—breast cancer	6.61e-06	0.000108	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—MDM2—breast cancer	6.59e-06	0.000107	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—RAF1—breast cancer	6.57e-06	0.000107	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—RELA—breast cancer	6.54e-06	0.000107	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—BRAF—breast cancer	6.53e-06	0.000106	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—ESR1—breast cancer	6.52e-06	0.000106	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—ERBB2—breast cancer	6.5e-06	0.000106	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—MTR—breast cancer	6.49e-06	0.000106	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CPT1A—breast cancer	6.49e-06	0.000106	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ABCG2—breast cancer	6.49e-06	0.000106	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—FN1—breast cancer	6.44e-06	0.000105	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—MTOR—breast cancer	6.41e-06	0.000104	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PIK3CB—breast cancer	6.41e-06	0.000104	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—NFKBIA—breast cancer	6.37e-06	0.000104	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—HPGDS—breast cancer	6.36e-06	0.000104	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—IGF1—breast cancer	6.36e-06	0.000104	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—AKT2—breast cancer	6.35e-06	0.000104	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—EGFR—breast cancer	6.33e-06	0.000103	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—HBA1—breast cancer	6.32e-06	0.000103	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—NOTCH1—breast cancer	6.31e-06	0.000103	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ACHE—breast cancer	6.17e-06	0.000101	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GSTT1—breast cancer	6.17e-06	0.000101	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PIK3CG—breast cancer	6.17e-06	0.000101	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—APC—breast cancer	6.17e-06	0.000101	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—KIT—breast cancer	6.17e-06	0.000101	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CXCL8—breast cancer	6.16e-06	0.0001	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—HRAS—breast cancer	6.12e-06	9.98e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PIK3CD—breast cancer	6.1e-06	9.95e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—EGF—breast cancer	6.1e-06	9.94e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—PIK3CA—breast cancer	6.05e-06	9.85e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—SERPINE1—breast cancer	6.04e-06	9.84e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CDKN1B—breast cancer	6.02e-06	9.81e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—KRAS—breast cancer	5.98e-06	9.74e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—AKT1—breast cancer	5.95e-06	9.7e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—MAPK3—breast cancer	5.91e-06	9.63e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CASP3—breast cancer	5.9e-06	9.61e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—IL2—breast cancer	5.89e-06	9.6e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—IL6—breast cancer	5.86e-06	9.55e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CYP17A1—breast cancer	5.84e-06	9.52e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—BRAF—breast cancer	5.8e-06	9.45e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ENO1—breast cancer	5.78e-06	9.43e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PTGS1—breast cancer	5.78e-06	9.43e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—NOS3—breast cancer	5.76e-06	9.39e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CCND1—breast cancer	5.74e-06	9.35e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—JUN—breast cancer	5.73e-06	9.33e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CTNNB1—breast cancer	5.68e-06	9.26e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CYP2D6—breast cancer	5.67e-06	9.25e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—IGF1—breast cancer	5.65e-06	9.2e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—AKT2—breast cancer	5.64e-06	9.2e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—EGFR—breast cancer	5.62e-06	9.16e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—MMP9—breast cancer	5.57e-06	9.08e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—NCOA2—breast cancer	5.57e-06	9.08e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CDKN1A—breast cancer	5.55e-06	9.05e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PTEN—breast cancer	5.54e-06	9.03e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—PIK3CA—breast cancer	5.49e-06	8.95e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—MDM2—breast cancer	5.47e-06	8.91e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—RAF1—breast cancer	5.45e-06	8.88e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—RELA—breast cancer	5.43e-06	8.84e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PIK3CD—breast cancer	5.42e-06	8.84e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—MAPK8—breast cancer	5.42e-06	8.83e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—AKT1—breast cancer	5.4e-06	8.81e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—FASN—breast cancer	5.4e-06	8.8e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—ERBB2—breast cancer	5.39e-06	8.79e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—BCHE—breast cancer	5.38e-06	8.77e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—PIK3CA—breast cancer	5.37e-06	8.75e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—SERPINE1—breast cancer	5.36e-06	8.74e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PIK3CB—breast cancer	5.32e-06	8.67e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—MTOR—breast cancer	5.32e-06	8.67e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—SLC5A5—breast cancer	5.31e-06	8.66e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—KRAS—breast cancer	5.31e-06	8.65e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—SRC—breast cancer	5.14e-06	8.37e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—SLC2A1—breast cancer	5.13e-06	8.36e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—NQO1—breast cancer	5.13e-06	8.36e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—NOS3—breast cancer	5.12e-06	8.34e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CXCL8—breast cancer	5.11e-06	8.33e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—HRAS—breast cancer	5.08e-06	8.28e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—VEGFA—breast cancer	5e-06	8.15e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CDKN1B—breast cancer	4.99e-06	8.14e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—STAT3—breast cancer	4.95e-06	8.07e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—AKT1—breast cancer	4.94e-06	8.05e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CYP1B1—breast cancer	4.92e-06	8.02e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CASP3—breast cancer	4.89e-06	7.98e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—IL2—breast cancer	4.89e-06	7.96e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—PIK3CA—breast cancer	4.88e-06	7.95e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—IL6—breast cancer	4.86e-06	7.92e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—MDM2—breast cancer	4.86e-06	7.92e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—RAF1—breast cancer	4.84e-06	7.89e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—HSP90AA1—breast cancer	4.82e-06	7.86e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—RELA—breast cancer	4.82e-06	7.85e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—ERBB2—breast cancer	4.79e-06	7.81e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CCND1—breast cancer	4.76e-06	7.76e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—JUN—breast cancer	4.75e-06	7.75e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—MAPK3—breast cancer	4.73e-06	7.71e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—MTOR—breast cancer	4.73e-06	7.7e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PIK3CB—breast cancer	4.73e-06	7.7e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CTNNB1—breast cancer	4.72e-06	7.69e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—NCOA1—breast cancer	4.69e-06	7.65e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—MMP9—breast cancer	4.62e-06	7.54e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CYP19A1—breast cancer	4.62e-06	7.54e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—STK11—breast cancer	4.62e-06	7.54e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CDKN1A—breast cancer	4.61e-06	7.51e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—MYC—breast cancer	4.6e-06	7.5e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PTEN—breast cancer	4.6e-06	7.49e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—TGFB1—breast cancer	4.59e-06	7.48e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CXCL8—breast cancer	4.54e-06	7.4e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—HRAS—breast cancer	4.51e-06	7.35e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—EGFR—breast cancer	4.5e-06	7.34e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—MAPK8—breast cancer	4.5e-06	7.33e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—AKT1—breast cancer	4.48e-06	7.31e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CDKN1B—breast cancer	4.43e-06	7.23e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—AKT1—breast cancer	4.39e-06	7.15e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CASP3—breast cancer	4.35e-06	7.08e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—IL2—breast cancer	4.34e-06	7.07e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—IL6—breast cancer	4.32e-06	7.04e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—COMT—breast cancer	4.3e-06	7.01e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GSTP1—breast cancer	4.28e-06	6.97e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—SRC—breast cancer	4.26e-06	6.95e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—KRAS—breast cancer	4.25e-06	6.93e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CCND1—breast cancer	4.23e-06	6.9e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—JUN—breast cancer	4.22e-06	6.88e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—HMOX1—breast cancer	4.22e-06	6.88e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ITPR1—breast cancer	4.21e-06	6.86e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CTNNB1—breast cancer	4.19e-06	6.83e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—VEGFA—breast cancer	4.15e-06	6.77e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—STAT3—breast cancer	4.11e-06	6.7e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—MMP9—breast cancer	4.11e-06	6.7e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CDKN1A—breast cancer	4.09e-06	6.67e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PTEN—breast cancer	4.08e-06	6.66e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ABCB1—breast cancer	4.05e-06	6.6e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—MAPK8—breast cancer	3.99e-06	6.51e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—AKT1—breast cancer	3.98e-06	6.49e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—TYMS—breast cancer	3.98e-06	6.48e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GSTM1—breast cancer	3.93e-06	6.41e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—NCOR1—breast cancer	3.93e-06	6.41e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PLA2G4A—breast cancer	3.93e-06	6.41e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—MAPK3—breast cancer	3.93e-06	6.4e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PIK3CA—breast cancer	3.91e-06	6.37e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—MYC—breast cancer	3.82e-06	6.23e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—TGFB1—breast cancer	3.81e-06	6.21e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—SRC—breast cancer	3.79e-06	6.17e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—TP53—breast cancer	3.78e-06	6.16e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GPX1—breast cancer	3.77e-06	6.14e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—EGFR—breast cancer	3.74e-06	6.09e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CYP1A1—breast cancer	3.73e-06	6.08e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ERCC2—breast cancer	3.7e-06	6.03e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—VEGFA—breast cancer	3.69e-06	6.01e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—STAT3—breast cancer	3.65e-06	5.95e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—HRAS—breast cancer	3.62e-06	5.89e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—KRAS—breast cancer	3.53e-06	5.75e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—MAPK3—breast cancer	3.49e-06	5.69e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—MTHFR—breast cancer	3.47e-06	5.66e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—IL6—breast cancer	3.46e-06	5.64e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—MYC—breast cancer	3.39e-06	5.53e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—TGFB1—breast cancer	3.39e-06	5.52e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—EGFR—breast cancer	3.32e-06	5.41e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PIK3CA—breast cancer	3.24e-06	5.29e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CAV1—breast cancer	3.21e-06	5.22e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—AKT1—breast cancer	3.19e-06	5.2e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—TP53—breast cancer	3.14e-06	5.11e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—KRAS—breast cancer	3.14e-06	5.11e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—HRAS—breast cancer	3e-06	4.89e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PIK3CG—breast cancer	2.92e-06	4.76e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PIK3CA—breast cancer	2.88e-06	4.7e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—IL6—breast cancer	2.87e-06	4.68e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—TP53—breast cancer	2.79e-06	4.54e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—HRAS—breast cancer	2.67e-06	4.34e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—AKT1—breast cancer	2.65e-06	4.32e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PIK3CD—breast cancer	2.57e-06	4.18e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—IL6—breast cancer	2.55e-06	4.16e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ALB—breast cancer	2.53e-06	4.13e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—NOS3—breast cancer	2.42e-06	3.95e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—AKT1—breast cancer	2.35e-06	3.84e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PIK3CB—breast cancer	2.24e-06	3.65e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PTGS2—breast cancer	2.22e-06	3.61e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PTEN—breast cancer	1.93e-06	3.15e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PIK3CA—breast cancer	1.36e-06	2.22e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—AKT1—breast cancer	1.11e-06	1.82e-05	CbGpPWpGaD
